APA

Fathy M. M., Abo Taleb M. E., El Hawary M. S., Nabih M. I., Aref W. M. & Makhlouf M. M. (20160318). Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients. : Cytokine.

Chicago

Fathy Mona M, Abo Taleb Mohamed E, El Hawary Mohamed S, Nabih Mona I, Aref Wael M and Makhlouf Manal M. 20160318. Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients. : Cytokine.

Harvard

Fathy M. M., Abo Taleb M. E., El Hawary M. S., Nabih M. I., Aref W. M. and Makhlouf M. M. (20160318). Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients. : Cytokine.

MLA

Fathy Mona M, Abo Taleb Mohamed E, El Hawary Mohamed S, Nabih Mona I, Aref Wael M and Makhlouf Manal M. Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients. : Cytokine. 20160318.